mechanism of action of glp 1 receptor agonists Glucagon-like peptide agonists: cardiovascular benefits and mechanisms GLP-1 Receptor Agonists as Treatments
Description
As a result, there is a growing argument to be made that providing coverage under group health plans to address obesity may be medically necessary and appropriate

The difference is FDA approval: Mounjaro is approved for type 2 diabetes, and Zepbound is approved for chronic weight management

This warning stems from studies in rodents where these medications caused dose-dependent and treatment-duration-dependent increases in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), at clinically relevant exposures

Awareness is up since July 2023, when about one in five (19%) said they heard a lot about the drugs. About eight in ten (79%) adults who have taken GLP-1 drugs report getting these drugs or a prescription for them from their primary care doctor or a specialist

Therefore, injections of semaglutide can assist individuals in maintaining a healthier lifestyle with a decrease in the rate of potential cardiovascular diseases [124]

doi: 10.1016/j.bbr.2015.07.024 144 CaiHYYangJTWangZJZhangJYangWWuMNet al
